Long-term follow up of chronic hepatitis C patients after α-interferon treatment: A functional study

Journal of Gastroenterology and Hepatology (Australia)

Volumn 16, Issue 4, 2001, Pages 399-405

  Giannini, Edoardo ^a   Fasoli, Alberto ^a   Botta, Federica ^a   Testa, Emanuela ^a   Romagnoli, Paola ^a   Ceppa, Paola ^b   Testa, Roberto ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Chronic hepatitis; Hepatitis C virus; Interferon; Monoethylglycinexylidide

Indexed keywords

ALPHA2A INTERFERON; ALPHA2B INTERFERON; DEETHYLLIDOCAINE; VIRUS RNA;

ADULT; ARTICLE; BIOCHEMISTRY; CHRONIC HEPATITIS; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LIVER FUNCTION; LIVER HISTOLOGY; MALE; PRIORITY JOURNAL; THROMBOCYTE COUNT; TREATMENT OUTCOME;

EID: 0035036127     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2001.02463.x     Document Type: Article

References (32)

1. Natural history of hepatitis C
2. Natural history of liver fibrosis progression in patients with chronic hepatitis C
3. Patterns of progression. Unpredictability and risk of decompensated cirrhosis
4. Histological evolution of chronic hepatitis C. Factors related to progression
5. Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: A French survey of 6,664 patients
6. A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis
7. Modeling the impact of interferon alfa treatment on liver fibrosis progression in chronic hepatitis C: A dynamic view
8. Interferon treatment of chronic hepatitis C with cirrhosis
9. Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis
10. Ten year follow-up of patients with chronic hepatitis C treated with interferon
11. Cirrhosis: Diagnosis by liver surface analysis with high-frequency ultrasound
12. Proposed abdominal sonograhic staging to predict severity of liver diseases analysis with peritoneoscopy and histology
13. AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection
14. Aspartate aminotransferase: Alanine aminotransferase ratio in chronic hepatitis C infection: Is it a useful predictor of cirrhosis?
15. Progressive liver functional impairment is associated to an increase in the AST/ALT ratio
16. Monoethylglycinexy-lidide test: A prognostic indicator of survival in cirrhosis
17. Predictors of one-year pretransplant survival in patients with cirrhosis
18. Measuring lidocaine metabolite-monoethylglycinexylidide as a quantitative index of hepatic function in adults with chronic hepatitis and cirrhosis
19. Hepatic lidocaine metabolism and liver histology in patients with chronic hepatitis and cirrhosis
20. Monoethylglycinexylidide formation measurement as a hepatic function test to assess severity of chronic liver disease
21. Histological determinants of monoethylglycinexylidide formation in patients with chronic hepatitis C
22. Variability of hepatitis C virus
23. Histological grading and staging of chronic hepatitis
24. Treatment of chronic hepatitis C with with recombinant interferon alpha
25. 10-Year follow-up after interferon-alpha therapy for chronic hepatitis C
26. Use of hepatic lidocaine metabolism to monitor patients with chronic liver disease
27. Quantitative liver function tests as surrogate markers for end-points in controlled clinical trials: A retrospective feasibility study
28. Review article: Quantitative tests of liver function
29. Steatosis and bile duct damage in chronic hepatitis C: Distribution and relationships in a group of Northern Italian patients
30. The effect of age on plasma MEGX concentrations
31. Long-term follow-up of chronic hepatitis C patients with sustained virological response to alpha-interferon
32. The effect of liver disease and food on plasma MEGX concentrations